Efficacy of antitussive drug (codeine phosphate) on cough patients evaluated by cough monitor

Efficacy of antitussive drug (codeine phosphate) on cough patients evaluated by cough monitor - Efficacy of antitussive drug evaluated by cough monitor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014384

Enrollment

Registered

2014-10-15

Start date

2014-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cough patients

Interventions

codeine phosphate 1% group placebo group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cough patients attending at the Department of Pulmonary Medicine, Fukushima Medical University Hospital

Exclusion criteria

Exclusion criteria: Infectious disease Treatment-free asthma and COPD Pregnant women or breast feeding women Patients who are unable to give informed consent. Inappropriate patients judged by respiratory physician.

Design outcomes

Primary

Measure	Time frame
The change of cough events before and after treatment of antitussive drug (codeine phosphate)	—

Secondary

Measure	Time frame
Cough VAS, LCQ (Leicester cough questionnaire), and capsaicin cough sensitivity test	—

Countries

Japan

Contacts

Public ContactAtsuro Fukuhara

Fukushima Medical University School of Medicine Department of Pulmonary Medicine

fukuhara@fmu.ac.jp024-547-1360

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026